Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

28.35
+0.98003.58%
Post-market: 28.350.00000.00%19:47 EDT
Volume:1.58M
Turnover:44.41M
Market Cap:4.53B
PE:-68.93
High:28.41
Open:27.59
Low:27.31
Close:27.37
52wk High:29.96
52wk Low:12.00
Shares:159.76M
Float Shares:125.00M
Volume Ratio:0.55
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4113
EPS(LYR):-0.3922
ROE:-38.76%
ROA:-4.12%
PB:31.69
PE(LYR):-72.29

Loading ...

Adaptive Biotechnologies Q1 Adjusted Ebitda USD -2.5 Million VS. Ibes Estimate USD -6.55 Million

THOMSON REUTERS
·
May 06

Stock Track | Adaptive Biotechnologies Plummets 5.03% Intraday Ahead of Q1 Earnings Report

Stock Track
·
May 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 04

Assessing Adaptive Biotechnologies (ADPT) Valuation After Recent Share Price Weakness

Simply Wall St.
·
May 03

Adaptive Biotech President, COO Julie Rubinstein sells 19,037 shares for $270,197.51

Reuters
·
Apr 30

Earning Preview: Adaptive Biotechnologies Corp Q1 revenue is expected to increase by 42.58%, and institutional views are cautiously bullish

Earnings Agent
·
Apr 29

Adaptive Biotechnologies President, COO Julie Rubinstein disposes of shares worth $802,123.4

Reuters
·
Apr 25

Adaptive Biotechnologies President, COO Julie Rubinstein sells $994,273 common shares

Reuters
·
Apr 22

Adaptive Biotechnologies President, COO Julie Rubinstein disposes of $832,436 common shares

Reuters
·
Apr 17

U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines

Reuters
·
Apr 14

Adaptive Biotechnologies Corp : TD Cowen Cuts Target Price to $19 From $21

THOMSON REUTERS
·
Apr 14

Adaptive Biotechnologies President and COO Julie Rubinstein sells USD 526,477 shares

Reuters
·
Apr 14

Adaptive Biotechnologies Chief People Officer Francis Lo sells $340,043 common shares

Reuters
·
Apr 11

Adaptive Biotech CSO Harlan Robins sells 10,000 shares worth $148,500

Reuters
·
Apr 11

Adaptive Biotechnologies CEO Chad Robins disposes of USD 1.8 million common shares

Reuters
·
Apr 09

Adaptive Biotechnologies President, COO Julie Rubinstein disposes of USD 983,470 shares

Reuters
·
Apr 09

Adaptive Biotechnologies (ADPT) Is Up 15.3% After Beating Q4 Views And Striking Pfizer Deals

Simply Wall St.
·
Apr 06